Transpact Enterprises informs about disclosure on material impact of covid-19

11 Aug 2020 Evaluate

Pursuant to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, Transpact Enterprises has informed that it has enclosed disclosure on material impact of COVID-19 pandemic on the Company.

The above information is a part of company’s filings submitted to BSE.

Transpact Enterprise Share Price

137.25 0.00 (0.00%)
08-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 436.50
Poly Medicure 1571.15
Laxmi Denta 222.30
Nureca Ltd. 299.70
Hemant Surgical Inds 266.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×